These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34897360)

  • 1. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
    Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
    Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.
    Yang TC; Liu SJ; Lo WL; Chen SM; Tang YL; Tseng YY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy to increase the therapeutic potency of GBM chemotherapy via altering parenchymal/cerebral spinal fluid clearance rate.
    Umlauf BJ; Frampton G; Cooper A; Greene HF
    J Control Release; 2023 Dec; 364():195-205. PubMed ID: 37865172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.
    Lam FC; Morton SW; Wyckoff J; Vu Han TL; Hwang MK; Maffa A; Balkanska-Sinclair E; Yaffe MB; Floyd SR; Hammond PT
    Nat Commun; 2018 May; 9(1):1991. PubMed ID: 29777137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
    Porru M; Zappavigna S; Salzano G; Luce A; Stoppacciaro A; Balestrieri ML; Artuso S; Lusa S; De Rosa G; Leonetti C; Caraglia M
    Oncotarget; 2014 Nov; 5(21):10446-59. PubMed ID: 25431953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma.
    Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH
    ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
    Kim JS; Shin DH; Kim JS
    J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
    Kim SS; Rait A; Kim E; Pirollo KF; Chang EH
    Nanomedicine; 2015 Feb; 11(2):301-11. PubMed ID: 25240597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.
    Zou Y; Wang Y; Xu S; Liu Y; Yin J; Lovejoy DB; Zheng M; Liang XJ; Park JB; Efremov YM; Ulasov I; Shi B
    Adv Mater; 2022 Aug; 34(33):e2203958. PubMed ID: 35738390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic.
    Chu W; Houston ZH; Fletcher NL; Huda P; Ahamed M; Lim TX; Day BW; Pinkham M; Thurecht KJ
    Biomacromolecules; 2023 Jun; 24(6):2674-2690. PubMed ID: 37143361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy.
    Sandbhor P; Goda JS; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2022 Sep; 14(35):12773-12788. PubMed ID: 36001382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-Decorated Exosomes for Combination Drug Delivery and Improved Glioma Therapy.
    Liang S; Xu H; Ye BC
    Langmuir; 2022 Jan; 38(1):299-308. PubMed ID: 34936368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound.
    Yang Q; Zhou Y; Chen J; Huang N; Wang Z; Cheng Y
    Int J Nanomedicine; 2021; 16():185-199. PubMed ID: 33447034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
    Yu Y; Wang A; Wang S; Sun Y; Chu L; Zhou L; Yang X; Liu X; Sha C; Sun K; Xu L
    Mol Pharm; 2022 Apr; 19(4):1219-1229. PubMed ID: 35262365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.
    Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W
    Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.